| DFAU | RFDA | DFAU / RFDA | |
| Gain YTD | 10.846 | 10.357 | 105% |
| Net Assets | 12.2B | 85.3M | 14,302% |
| Total Expense Ratio | 0.12 | 0.52 | 23% |
| Turnover | 5.00 | 1.00 | 500% |
| Yield | 0.90 | 1.78 | 50% |
| Fund Existence | 6 years | 10 years | - |
| DFAU | RFDA | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 77% | 3 days ago 68% |
| Stochastic ODDS (%) | 3 days ago 73% | 3 days ago 84% |
| Momentum ODDS (%) | 3 days ago 76% | 3 days ago 76% |
| MACD ODDS (%) | 3 days ago 70% | 3 days ago 68% |
| TrendWeek ODDS (%) | 3 days ago 84% | 3 days ago 71% |
| TrendMonth ODDS (%) | 3 days ago 83% | 3 days ago 83% |
| Advances ODDS (%) | 6 days ago 82% | 9 days ago 83% |
| Declines ODDS (%) | 4 days ago 73% | 13 days ago 70% |
| BollingerBands ODDS (%) | 3 days ago 90% | 3 days ago 78% |
| Aroon ODDS (%) | 3 days ago 82% | 3 days ago 82% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| IJPIX | 18.10 | 0.61 | +3.49% |
| VY® JPMorgan Emerging Markets Equity S | |||
| FOSBX | 34.36 | 0.61 | +1.81% |
| Tributary Small Company Instl Plus | |||
| FDVIX | 32.56 | 0.50 | +1.56% |
| Fidelity Advisor Diversified Intl I | |||
| TIDDX | 81.85 | 0.56 | +0.69% |
| T. Rowe Price International Discovery I | |||
| SHPCX | 13.80 | -0.13 | -0.93% |
| Saratoga Health & Biotechnology C | |||
A.I.dvisor tells us that RFDA and BAC have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RFDA and BAC's prices will move in lockstep.
| Ticker / NAME | Correlation To RFDA | 1D Price Change % | ||
|---|---|---|---|---|
| RFDA | 100% | +0.04% | ||
| BAC - RFDA | 20% Poorly correlated | -0.58% | ||
| MMM - RFDA | 18% Poorly correlated | +0.86% | ||
| HBNC - RFDA | 18% Poorly correlated | +0.47% | ||
| BMY - RFDA | 15% Poorly correlated | -2.32% | ||
| META - RFDA | 14% Poorly correlated | +1.70% | ||
More | ||||